Daratumumab rapidly reduces high-titre factor VIII inhibitors in haemophilia A patients during life-threatening haemorrhages.
Moonla C, Uaprasert N, Watanaboonyongcharoen P, Meesanun M, Sukperm A, Jantasing R, Faknuam S, Chanswangphuwana C, Polprasert C, Sodsai P, Akkawat B, Hirankarn N, Bunworasate U, Rojnuckarin P.
Moonla C, et al. Among authors: uaprasert n.
Haemophilia. 2021 Jan;27(1):e155-e159. doi: 10.1111/hae.14118. Epub 2020 Aug 25.
Haemophilia. 2021.
PMID: 32842168
No abstract available.